FDA issues Warning letter to Sure Biochem Laboratories, USA a contract testing laboratory conducting microbial testing of finished drugs. Warning letter cites deficient growth promotion testing (GPT) of media, failure to validate alternate microbial methods used to test drug products, failure to detect Burkholderia cepacia complex (Bcc) in drug product; lapses in documentation of test data and document retention Read More..
Leave a Comment
You must be logged in to post a comment.